Objectives: Molecular oncology (GO) is a discipline that focuses on the diagnosis, staging, prognosis, and management of cancer with the help of molecular genetics. Increasing understanding of the molecular changes that drive tumor progression has transformed the treatment of this disease. The main goal of this study was to describe the current situation in India regarding the knowledge, attitude, and practice of molecular oncology through an online survey of oncologists. Material and Methods: A descriptive survey was sent to several hospitals by means of E-mails and social media. Results: Between December 2019 and February 2020, 74 responses were collected. All of the respondents were interested in the accreditation of the reports and authorizing agency accrediting them. About 68.9% of the practicing oncologist did not have any provision of molecular oncology tumor board. 82.4% of the oncologists reviewed with the molecular pathologist for discussion of the molecular reports. On the contrary, 58.1% of the oncologist never received any information from the reporting team about the patient clinical details, follow-up, or changes in the reports ever. About 79.7% of the prescribing oncologist were interested in remuneration in any form for prescribing such tests. About 27% of the oncologist were not aware of any accreditation agency available in India for molecular oncology reports. Conclusion: From the nationwide survey, we conclude that there is an increasing perception of the need for training in molecular oncology. This survey reflects a reality, in which specific needs are perceived.
[1]
Jonathan M Marron,et al.
Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience
,
2016,
Pediatric blood & cancer.
[2]
R. Gibbs,et al.
Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients
,
2014,
Genome Medicine.
[3]
N. Pavlidis,et al.
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
,
2013,
Annals of oncology : official journal of the European Society for Medical Oncology.
[4]
Manfred Dietel,et al.
Personalized medicine and development of targeted therapies: the upcoming challenge for diagnostic molecular pathology. A review
,
2006,
Virchows Archiv.
[5]
H. Cohen,et al.
NCCN Guidelines ® Insights Older Adult Oncology, Version 2.2016 Featured Updates to the NCCN Guidelines
,
2016
.
[6]
Christine H Chung,et al.
Genomics and proteomics: emerging technologies in clinical cancer research.
,
2007,
Critical reviews in oncology/hematology.